This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jan 12;354(2):189-91.

doi: 10.1056/NEJMe058295.

Optimizing ACE-inhibitor therapy for chronic kidney disease

PMID: 16407515
DOI: 10.1056/NEJMe058295

Editorial

Optimizing ACE-inhibitor therapy for chronic kidney disease

Lee A Hebert. N Engl J Med. 2006.

. 2006 Jan 12;354(2):189-91.

doi: 10.1056/NEJMe058295.

Author

PMID: 16407515
DOI: 10.1056/NEJMe058295

No abstract available

PubMed Disclaimer

Comment in

Benazepril for advanced chronic renal insufficiency.
Bloom JM. Bloom JM. N Engl J Med. 2006 Apr 6;354(14):1530-1; author reply 1530-1. doi: 10.1056/NEJMc060298. N Engl J Med. 2006. PMID: 16598052 No abstract available.

Comment on

Efficacy and safety of benazepril for advanced chronic renal insufficiency.
Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW. Hou FF, et al. N Engl J Med. 2006 Jan 12;354(2):131-40. doi: 10.1056/NEJMoa053107. N Engl J Med. 2006. PMID: 16407508 Clinical Trial.

Similar articles

The use of ACE inhibitors and ARBs in severe chronic kidney disease: point-counterpoint.
Creamer LM, Ryan J. Creamer LM, et al. CANNT J. 2008 Oct-Dec;18(4):46-8. CANNT J. 2008. PMID: 19175194 Review. No abstract available.
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
Phillips CO, Kashani A, Ko DK, Francis G, Krumholz HM. Phillips CO, et al. Arch Intern Med. 2007 Oct 8;167(18):1930-6. doi: 10.1001/archinte.167.18.1930. Arch Intern Med. 2007. PMID: 17923591 Review.
Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
Ripley E. Ripley E. Am Heart J. 2009 Jun;157(6 Suppl):S7-S16. doi: 10.1016/j.ahj.2009.04.008. Am Heart J. 2009. PMID: 19450722 Review.
Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
Toto R, Palmer BF. Toto R, et al. Am J Nephrol. 2008;28(3):372-80. doi: 10.1159/000112269. Epub 2007 Dec 12. Am J Nephrol. 2008. PMID: 18073461 Review.
Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Cohen DL, Townsend RR. Cohen DL, et al. J Am Soc Nephrol. 2009 Aug;20(8):1666-8. doi: 10.1681/ASN.2008040381. Epub 2008 Sep 5. J Am Soc Nephrol. 2009. PMID: 18776118

See all similar articles

Cited by

Is fluid overload as measured by bioimpedance spectroscopy harmful in CKD-if so, why?
Hebert LA, Parikh S. Hebert LA, et al. Clin J Am Soc Nephrol. 2015 Jan 7;10(1):1-3. doi: 10.2215/CJN.11311114. Epub 2014 Dec 15. Clin J Am Soc Nephrol. 2015. PMID: 25512645 Free PMC article. No abstract available.
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.
Johnson ES, Weinstein JR, Thorp ML, Platt RW, Petrik AF, Yang X, Anderson S, Smith DH. Johnson ES, et al. Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):266-72. doi: 10.1002/pds.1923. Pharmacoepidemiol Drug Saf. 2010. PMID: 20112435 Free PMC article.
Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease.
Inampudi C, Alvarez P, Asleh R, Briasoulis A. Inampudi C, et al. Curr Cardiol Rev. 2018 Mar 14;14(1):60-66. doi: 10.2174/1573403X14666180123164916. Curr Cardiol Rev. 2018. PMID: 29366423 Free PMC article. Review.
Renal dysfunction in heart failure patients: what is the evidence?
Saltzman HE, Sharma K, Mather PJ, Rubin S, Adams S, Whellan DJ. Saltzman HE, et al. Heart Fail Rev. 2007 Mar;12(1):37-47. doi: 10.1007/s10741-007-9006-5. Epub 2007 Mar 29. Heart Fail Rev. 2007. PMID: 17393304 Review.
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
Ahmed A, Fonarow GC, Zhang Y, Sanders PW, Allman RM, Arnett DK, Feller MA, Love TE, Aban IB, Levesque R, Ekundayo OJ, Dell'Italia LJ, Bakris GL, Rich MW. Ahmed A, et al. Am J Med. 2012 Apr;125(4):399-410. doi: 10.1016/j.amjmed.2011.10.013. Epub 2012 Feb 7. Am J Med. 2012. PMID: 22321760 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal